SCHEMBL20604758

SCHEMBL20604758

Cc1cccn2nc(-c3ccc4c(ccn4C)c3)nc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.48
AHR P35869 1/20 0.43
KDM1A O60341 1/20 0.40
PDE10A Q9Y233 1/20 0.40
FAAH O00519 4/20 0.39
TGFBR1 P36897 1/20 0.39
PRKCI P41743 1/20 0.39
DHODH Q02127 1/20 0.39
SRC P12931 4/20 0.38
ABL1 P00519 2/20 0.38
PIK3CD O00329 1/20 0.38
EGFR P00533 1/20 0.38
HCK P08631 1/20 0.38
KDR P35968 1/20 0.38
PIK3CA P42336 1/20 0.38
PIK3CB P42338 1/20 0.38
MTOR P42345 1/20 0.38
PIK3CG P48736 1/20 0.38
EPHB4 P54760 1/20 0.38
PRKDC P78527 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26581740 0.82 AHR (0.41) AHRPDE10ADHODHKDR
SCHEMBL20604823 0.81 HSD11B1 (0.40) HSD11B1AHRKDM1AFAAHPRKCI
SCHEMBL20604969 0.79 PDE10A (0.39) AHRPDE10ADHODHKDR
SCHEMBL20605042 0.78 HSD11B1 (0.50) HSD11B1KDM1APDE10AFAAHTGFBR1
SCHEMBL23809312 0.77 PDE10A (0.38) AHRPDE10ADHODHKDR
SCHEMBL20605063 0.76 HSD11B1 (0.52) HSD11B1KDM1AFAAHTGFBR1PRKCI
SCHEMBL20604970 0.76 HSD11B1 (0.36) HSD11B1AHRKDM1AFAAHSRC
SCHEMBL30309638 0.76 TDP2 (0.50) AHRPDE10A
SCHEMBL21041198 0.75 DHODH (0.57) AHRPDE10ADHODHEGFR
SCHEMBL20605109 0.75 HSD11B1 (0.46) HSD11B1AHRKDM1APDE10AFAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12144816-B2 Substituted indole Mcl-1 inhibitors VANDERBILT UNIVERSITY (US) 2024-11-19 US disclosed
EP-4292662-A2 SUBSTITUTED INDOLE MCL-1 INHIBITORS Vanderbilt University (US) 2023-12-20 EP disclosed
US-20230330099-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS VANDERBILT UNIVERSITY 2023-10-19 US disclosed
EP-3423435-B1 SUBSTITUTED INDOLE MCL-1 INHIBITORS UNIV VANDERBILT (US) 2023-08-23 EP disclosed
US-11596639-B2 Substituted indole Mcl-1 inhibitors VANDERBILT UNIVERSITY (US) 2023-03-07 US disclosed
US-20210283138-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS VANDERBILT UNIVERSITY 2021-09-16 US disclosed
EP-3423435-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS Vanderbilt University (US) 2019-01-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210283138-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS MCL1, BCL2L1, BCL9 HSD11B1 4071/4885AHR 752/4885KDM1A 854/4885
US-12144816-B2 Substituted indole Mcl-1 inhibitors MCL1, BCL2L1, BCL9 HSD11B1 4071/4885AHR 752/4885KDM1A 854/4885
US-20230330099-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS MCL1, BCL2L1, BCL9 HSD11B1 4071/4885AHR 752/4885KDM1A 854/4885
US-11596639-B2 Substituted indole Mcl-1 inhibitors MCL1, BCL2L1, BCL9 HSD11B1 4071/4885AHR 752/4885KDM1A 854/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.